RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2015-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Your saved research and appointment questionsView recorded trial and retraction changes
Trichohepatoenteric Syndrome: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Humoral Immune Variability in Twin Sisters With SKIV2L-Associated Trichohepatoenteric Syndrome
Shreena G Reddy et al., Cureus (31 August 2026)
https://doi.org/10.7759/cureus.115524
- 2.
Tricho-Hepato-Enteric Syndromic Immunodeficiency: Clinical Spectrum, Pathobiology, and Emerging Therapies.
Mandola Amarilla B et al., The Israel Medical Association journal : IMAJ (1 August 2026)
https://pubmed.ncbi.nlm.nih.gov/42557665/
- 3.
Two Cases of Tricho-Hepato-Enteric Syndrome with Novel Mutations and 3-Year Follow-up
, Journal of College of Physicians And Surgeons Pakistan (1 January 2026)
https://doi.org/10.29271/jcpspcr.2026.232
- 4.
Reduced immunoglobulin requirement after dupilumab for atopic dermatitis in trichohepatoenteric syndrome.
Cheng-Xun Silas Choe et al., Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (1 January 2026)
https://pubmed.ncbi.nlm.nih.gov/41531377/
- 5.
TRICHOHEPATOENTERIC SYNDROME WITHOUT DIARRHEA: AN ATYPICAL PRESENTATION OF VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE
S. Han et al., Annals of Allergy Asthma & Immunology (1 November 2025)
https://doi.org/10.1016/j.anai.2025.08.547
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Trichohepatoenteric Syndrome
Trichohepatoenteric syndrome is a rare inherited condition that begins in the first months of life with severe watery diarrhoea that does not settle with fasting. Babies also have woolly, brittle hair, poor growth, distinctive facial features, and often liver and immune problems. Care involves intravenous or specialised feeding, nutritional support and treatment of liver and infection complications.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
There is not much recent research on Trichohepatoenteric Syndrome, so this page includes research published since 2015. Most pages on RareWays start at 2020.
Most Recent Research
Common Questions
What is Trichohepatoenteric Syndrome?
Trichohepatoenteric syndrome is a rare inherited condition that begins in the first months of life with severe watery diarrhoea that does not settle with fasting. Babies also have woolly, brittle hair, poor growth, distinctive facial features, and often liver and immune problems. Care involves intravenous or specialised feeding, nutritional support and treatment of liver and infection complications.
How many clinical trials are available for Trichohepatoenteric Syndrome?
No clinical trials are currently indexed for Trichohepatoenteric Syndrome. This may change as new trials are registered. Check back regularly or visit ClinicalTrials.gov directly.
Where does the research data for Trichohepatoenteric Syndrome come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Trichohepatoenteric Syndrome.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.